Skip to main content

Oric Pharmaceuticals, Inc.

ORIC
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001796280

In the last 90 days, Oric Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 5 sales; 180 institutions reported holding it in 13F filings for Q2 2026, worth $1.34B in total; Viking Global Investors is the only superinvestor holding it.

Q3 2024 vs. Q2 2024

How the institutions holding Oric Pharmaceuticals, Inc. changed between Q2 2024 and Q3 2024.

All holders in Q3 2024All holders in Q2 2024

13F holders of ORIC: Q2 2024 compared with Q3 2024
MeasureQ2 2024Of which not filed for Q3 2024Q3 2024Change
Holders1132122+11
Shares67.6M5.84M69.8M+8.01M (+13.0%)
Value$478.3M$41.3M$715.1M+$278.1M (+63.6%)

2 institutions that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (24)

Institutions that held Oric Pharmaceuticals, Inc. at the end of Q3 2024 but not at the end of Q2 2024.

Institutions new to ORIC in Q3 2024
InstitutionSharesValue% of portfolio
BlackRock, Inc.5,101,817$52.3M0.00%
Avidity Partners Management LP1,447,119$14.8M0.76%
Balyasny Asset Management LLC1,131,066$11.6M0.03%
Siren, L.L.C.1,007,575$10.3M0.52%
Superstring Capital Management LP949,522$9.73M8.70%
Sphera Funds Management Ltd.128,396$1.32M0.22%
Deerfield Management Company, L.P. (Series C)78,435$804.0K0.01%
SG Americas Securities, LLC69,620$714.0K0.00%
Campbell & CO Investment Adviser LLC27,241$279.2K0.02%
Trexquant Investment LP25,220$258.5K0.00%
Intech Investment Management LLC19,468$199.5K0.00%
ProShare Advisors LLC15,802$162.0K0.00%
Connor, Clark & Lunn Investment Management Ltd.12,832$131.5K0.00%
Creative Planning11,272$115.5K0.00%
Ameriprise Financial Inc11,109$113.9K0.00%
Shell Asset Management Co8,824$90.0K0.00%
Citadel Advisors LLC5,767$59.1K0.00%
Acadian Asset Management LLC2,309$23.0K0.00%
Federation des caisses Desjardins du Quebec2,000$20.5K0.00%
Smartleaf Asset Management LLC870$9.27K0.00%
Sterling Capital Management LLC182$1.87K0.00%
NBC Securities, Inc.118$1.00K0.00%
Bessemer Group Inc120$1.00K0.00%
Capital Performance Advisors LLP1$100.00%

Sold out (13)

Institutions that held Oric Pharmaceuticals, Inc. at the end of Q2 2024 and filed for Q3 2024 without it.

Institutions that sold out of ORIC in Q3 2024
InstitutionShares, Q2 2024Value, Q2 2024
OrbiMed Advisors LLC287,100$2.03M
Soleus Capital Management, L.P.163,000$1.15M
Acuta Capital Partners, LLC96,000$678.7K
Qube Research & Technologies Ltd81,227$574.3K
Atom Investors LP36,901$260.9K
State of Wisconsin Investment Board36,223$256.1K
DAFNA Capital Management LLC36,000$254.5K
Tudor Investment Corp Et Al33,391$236.1K
Alpine Global Management, LLC22,815$161.3K
Jump Financial, LLC19,723$139.4K
AQR Capital Management LLC12,241$86.5K
Russell Investments Group, Ltd.1,105$7.81K
Pacer Advisors, Inc.661$4.67K

Not filed for Q3 2024 yet (2)

Institutions that held Oric Pharmaceuticals, Inc. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding ORIC in Q2 2024 that haven't filed for Q3 2024
InstitutionShares, Q2 2024Value, Q2 2024
BlackRock Inc.4,830,880$34.2M
Invus Financial Advisors, LLC1,007,575$7.12M